• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅰ型干扰素引起的血管内皮反应导致血管病变和纤维化,并预测系统性硬化症的疾病进展。

Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.

机构信息

Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

出版信息

Arthritis Rheumatol. 2024 Jan;76(1):78-91. doi: 10.1002/art.42662.

DOI:10.1002/art.42662
PMID:37488975
Abstract

OBJECTIVE

Interferon (IFN)-1 signatures are a hallmark of patients with systemic sclerosis (SSc). However, its significance in clinical stratification and contribution to deterioration still need to be better understood.

METHODS

For hypothesis generation, we performed single-cell RNA sequencing (scRNA-seq) on skin biopsies (four patients with SSc and two controls) using the BD Rhapsody platform. Two publicly available data sets of skin scRNA-seq were used for validation (GSE138669: 12 patients with diffuse cutaneous SSc [dcSSc] and 10 controls; GSE195452: 52 patients with dcSSc and 41 patients with limited cutaneous SSc [lcSSc] and 54 controls). The IFN-1 signature was mapped, functionally investigated in a bleomycin plus IFNα-2 adenovirus-associated virus (AAV)-induced model and verified in an SSc cohort (n = 61).

RESULTS

The discovery and validation data sets showed similar findings. Endothelial cells (ECs) had the most prominent IFN-1 signature among dermal nonimmune cells. The EC IFN-1 signature was increased both in patients with SSc versus controls and in patients with dcSSc versus those with lcSSc. Among EC subclusters, the IFN-1 signature was statistically higher in the capillary ECs of patients with dcSSc, which was higher than those in patients with lcSSc, which in turn was higher than those in healthy controls (HCs). Endothelial-to-mesenchymal transition (EndoMT) scores increased in parallel. Deteriorated bleomycin-induced dermal fibrosis, EndoMT, and perivascular fibrosis and caused blood vessel loss with EC apoptosis. Vascular myxovirus resistance (MX) 1, an IFN-1 response protein, was significantly increased both in total SSc versus HC skin and in dcSSc versus lcSSc skin. Baseline vascular MX1 performed similarly to skin score in predicting disease progression over 6 to 34 months in total SSc and was superior in the dcSSc subpopulation.

CONCLUSION

The EC IFN-1 signature distinguished SSc skin subtypes and disease progression and may contribute to vasculopathy and fibrosis.

摘要

目的

干扰素(IFN)-1 特征是全身性硬皮病(SSc)患者的一个标志。然而,其在临床分层中的意义及其对病情恶化的影响仍需要进一步了解。

方法

为了提出假设,我们使用 BD Rhapsody 平台对皮肤活检(四名 SSc 患者和两名对照者)进行单细胞 RNA 测序(scRNA-seq)。使用两个公开的皮肤 scRNA-seq 数据集进行验证(GSE138669:12 名弥漫性皮肤 SSc [dcSSc] 患者和 10 名对照者;GSE195452:52 名 dcSSc 患者和 41 名局限性皮肤 SSc [lcSSc] 患者和 54 名对照者)。映射 IFN-1 特征,在博来霉素加 IFNα-2 腺相关病毒(AAV)诱导的模型中进行功能研究,并在 SSc 队列(n=61)中进行验证。

结果

发现和验证数据集显示出相似的结果。真皮非免疫细胞中内皮细胞(ECs)具有最显著的 IFN-1 特征。与对照组相比,SSc 患者和与 lcSSc 患者相比,dcSSc 患者的 EC IFN-1 特征均增加。在 EC 亚群中,dcSSc 患者的毛细血管 ECs 的 IFN-1 特征统计学上更高,高于 lcSSc 患者,而 lcSSc 患者又高于健康对照者(HCs)。内皮-间充质转化(EndoMT)评分也随之增加。恶化的博来霉素诱导的皮肤纤维化、EndoMT 和血管周围纤维化导致血管损失和 EC 凋亡。血管粘液病毒抗性(MX)1,一种 IFN-1 反应蛋白,在总 SSc 与 HC 皮肤相比和在 dcSSc 与 lcSSc 皮肤相比均显著增加。在总 SSc 中,基线血管 MX1 在预测 6 至 34 个月的疾病进展方面与皮肤评分相似,在 dcSSc 亚群中更具优势。

结论

EC IFN-1 特征区分了 SSc 皮肤亚型和疾病进展,可能与血管病变和纤维化有关。

相似文献

1
Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.Ⅰ型干扰素引起的血管内皮反应导致血管病变和纤维化,并预测系统性硬化症的疾病进展。
Arthritis Rheumatol. 2024 Jan;76(1):78-91. doi: 10.1002/art.42662.
2
A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.组织蛋白酶 B 表达改变可能有助于系统性硬皮病皮肤硬化和血管病变的发生。
PLoS One. 2012;7(2):e32272. doi: 10.1371/journal.pone.0032272. Epub 2012 Feb 23.
3
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.内皮细胞向间充质转化促进系统性硬皮病的内皮功能障碍和皮肤纤维化。
Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6.
4
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.由于 Fli1 缺陷导致组织蛋白酶 V 表达减少,导致系统性硬化症皮肤纤维化和增生性血管病变的发展。
Rheumatology (Oxford). 2013 May;52(5):790-9. doi: 10.1093/rheumatology/kes379. Epub 2013 Jan 3.
5
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.I 型干扰素特征在系统性硬化症出现明显纤维化之前就已存在,可能通过高 BAFF 基因表达和高胶原蛋白合成来促进其发病机制。
Ann Rheum Dis. 2016 Aug;75(8):1567-73. doi: 10.1136/annrheumdis-2015-207392. Epub 2015 Sep 14.
6
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.无皮肤硬化系统性硬皮病患者的皮肤表现、临床特征和预后:来自国际 EUSTAR 数据库的数据。
JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729.
7
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.局限性皮肤系统性硬化症患者的结局:来自 EUSTAR 数据库的超过 12000 例患者的结果。
Autoimmun Rev. 2020 Feb;19(2):102452. doi: 10.1016/j.autrev.2019.102452. Epub 2019 Dec 12.
8
Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.单细胞 RNA 测序鉴定 HSPG2 和 APLNR 为系统性硬化症皮肤内皮细胞损伤的标志物。
Front Immunol. 2018 Oct 1;9:2191. doi: 10.3389/fimmu.2018.02191. eCollection 2018.
9
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.干扰素调节因子 7(IRF7)在系统性硬化症的发病机制中代表了炎症和纤维化之间的联系。
Ann Rheum Dis. 2019 Nov;78(11):1583-1591. doi: 10.1136/annrheumdis-2019-215208. Epub 2019 Aug 22.
10
Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.局限性皮肤型系统性硬化症患者血清中白细胞介素-33中和性sST2水平升高。
Scand J Immunol. 2015 Sep;82(3):269-74. doi: 10.1111/sji.12317.

引用本文的文献

1
Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4).转化生长因子β(TGF-β)通过氯离子细胞内通道4(CLIC4)诱导系统性硬化症角质形成细胞中的1型干扰素信号传导。
Arthritis Res Ther. 2025 Sep 1;27(1):173. doi: 10.1186/s13075-025-03632-6.
2
Microvascular Density Analysis of Patients with Trigeminal Herpes Zoster-An Optical Coherence Tomography Angiography Study.三叉神经带状疱疹患者的微血管密度分析——一项光学相干断层扫描血管造影研究
Biomedicines. 2025 Jul 3;13(7):1630. doi: 10.3390/biomedicines13071630.
3
Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis.
用于预测局限性皮肤型系统性硬化症中有临床意义的疾病进展的血清I型干扰素评分
Arthritis Rheumatol. 2025 Jul;77(7):929-941. doi: 10.1002/art.43120. Epub 2025 Mar 3.
4
Exploring novel markers for coronary heart disease associated with systemic lupus erythematosus: A review.探索与系统性红斑狼疮相关的冠心病新标志物:综述
Medicine (Baltimore). 2024 Dec 13;103(50):e40773. doi: 10.1097/MD.0000000000040773.
5
Mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis: role and therapeutic directions.间充质干细胞衍生的细胞外囊泡在系统性硬化症中的作用及治疗方向
Front Cell Dev Biol. 2024 Oct 17;12:1492821. doi: 10.3389/fcell.2024.1492821. eCollection 2024.
6
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis.系统性硬化症中血管生成缺陷的细胞和分子机制的最新见解
Biomedicines. 2024 Jun 14;12(6):1331. doi: 10.3390/biomedicines12061331.
7
Animal models in systemic sclerosis: an update.系统性硬化症的动物模型:最新进展。
Curr Opin Rheumatol. 2023 Nov 1;35(6):364-370. doi: 10.1097/BOR.0000000000000967. Epub 2023 Aug 21.